|Day Low/High||118.20 / 120.47|
|52 Wk Low/High||92.65 / 143.37|
MAA seeking regulatory approval of Epidiolex for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.
Look for this name to jump quickly in popularity in 2018 as investors players search for a convenient way to play the marijuana niche.
Consumers in California eagerly await the end to it prohibition on the recreational use of cannabis.
- Previous License Agreement with Otsuka Terminated -
Party leaders will have to work toward merging the two versions of tax reform into one final bill.
From tax cuts to the Flynn fallout, Jim Cramer says investors have to be covered.
Over 20 abstracts released online today from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet syndrome and from Expanded Access Program
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.